Abdominal Wall Defect

Categories: Gastrointestinal diseases, Respiratory diseases

Aliases & Classifications for Abdominal Wall Defect

Summaries for Abdominal Wall Defect

Genetics Home Reference : 25 An abdominal wall defect is an opening in the abdomen through which various abdominal organs can protrude. This opening varies in size and can usually be diagnosed early in fetal development, typically between the tenth and fourteenth weeks of pregnancy. There are two main types of abdominal wall defects: omphalocele and gastroschisis. Omphalocele is an opening in the center of the abdominal wall where the umbilical cord meets the abdomen. Organs (typically the intestines, stomach, and liver) protrude through the opening into the umbilical cord and are covered by the same protective membrane that covers the umbilical cord. Gastroschisis is a defect in the abdominal wall, usually to the right of the umbilical cord, through which the large and small intestines protrude (although other organs may sometimes bulge out). There is no membrane covering the exposed organs in gastroschisis. Fetuses with omphalocele may grow slowly before birth (intrauterine growth retardation) and they may be born prematurely. Individuals with omphalocele frequently have multiple birth defects, such as a congenital heart defect. Additionally, underdevelopment of the lungs is often associated with omphalocele because the abdominal organs normally provide a framework for chest wall growth. When those organs are misplaced, the chest wall does not form properly, providing a smaller than normal space for the lungs to develop. As a result, many infants with omphalocele have respiratory insufficiency and may need to be supported with a machine to help them breathe (mechanical ventilation). Rarely, affected individuals who have breathing problems in infancy experience recurrent lung infections or asthma later in life. Affected infants often have gastrointestinal problems including a backflow of stomach acids into the esophagus (gastroesophageal reflux) and feeding difficulty; these problems can persist even after treatment of omphalocele. Large omphaloceles or those associated with multiple additional health problems are more often associated with fetal death than cases in which omphalocele occurs alone (isolated). Omphalocele is a feature of many genetic syndromes. Nearly half of individuals with omphalocele have a condition caused by an extra copy of one of the chromosomes in each of their cells (trisomy). Up to one-third of people born with omphalocele have a genetic condition called Beckwith-Wiedemann syndrome. Affected individuals may have additional signs and symptoms associated with these genetic conditions. Individuals who have gastroschisis rarely have other birth defects and seldom have chromosome abnormalities or a genetic condition. Most affected individuals experience intrauterine growth retardation and are small at birth; many affected infants are born prematurely. With gastroschisis, the protruding organs are not covered by a protective membrane and are susceptible to damage due to direct contact with amniotic fluid in the womb. Components of the amniotic fluid may trigger immune responses and inflammatory reactions against the intestines that can damage the tissue. Constriction around exposed organs at the abdominal wall opening late in fetal development may also contribute to organ injury. Intestinal damage causes impairment of the muscle contractions that move food through the digestive tract (peristalsis) in most children with gastroschisis. In these individuals, peristalsis usually improves in a few months and intestinal muscle contractions normalize. Rarely, children with gastroschisis have a narrowing or absence of a portion of intestine (intestinal atresia) or twisting of the intestine. After birth, these intestinal malformations can lead to problems with digestive function, further loss of intestinal tissue, and a condition called short bowel syndrome that occurs when areas of the small intestine are missing, causing dehydration and poor absorption of nutrients. Depending on the severity of the condition, intravenous feedings (parenteral nutrition) may be required. The health of an individual with gastroschisis depends largely on how damaged his or her intestine was before birth. When the abdominal wall defect is repaired and normal intestinal function is recovered, the vast majority of affected individuals have no health problems related to the repaired defect later in life.

MalaCards based summary : Abdominal Wall Defect, also known as gastroschisis, is related to shprintzen omphalocele syndrome and omphalocele-cleft palate syndrome, lethal. The drugs Bupivacaine and Ketorolac have been mentioned in the context of this disorder. Affiliated tissues include liver, small intestine and heart.

Wikipedia : 74 Abdominal wall defects are a type of congenital defect that allows the stomach, the intestines, or other... more...

Related Diseases for Abdominal Wall Defect

Diseases related to Abdominal Wall Defect via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 444)
# Related Disease Score Top Affiliating Genes
1 shprintzen omphalocele syndrome 12.7
2 omphalocele-cleft palate syndrome, lethal 12.7
3 omphalocele, diaphragmatic hernia, and radial ray defects 12.4
4 omphalocele, x-linked 12.3
5 shprintzen-goldberg craniosynostosis syndrome 12.2
6 diaphragmatic agenesis radial aplasia omphalocele 12.2
7 familial omphalocele syndrome with facial dysmorphism 12.2
8 hydrocephalus with associated malformations 11.9
9 oeis complex 11.8
10 beckwith-wiedemann syndrome 11.7
11 pagod syndrome 11.7
12 cloacal exstrophy 11.7
13 gastroschisis 11.7
14 omphalocele 11.6
15 otopalatodigital syndrome, type ii 11.6
16 boomerang dysplasia 11.6
17 donnai-barrow syndrome 11.6
18 paraomphalocele 11.6
19 constricting bands, congenital 11.5
20 omphalocele, autosomal 11.5
21 miller-dieker lissencephaly syndrome 11.4
22 acrocephalopolydactylous dysplasia 11.4
23 fibrochondrogenesis 11.4
24 schisis association 11.4
25 manitoba oculotrichoanal syndrome 11.4
26 kagami-ogata syndrome 11.3
27 gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy 11.2
28 fryns microphthalmia syndrome 11.2
29 hyperthermia induced defects 11.2
30 hyperekplexia 11.2
31 hypertelorism, teebi type 11.1
32 3mc syndrome 3 11.1
33 3mc syndrome 1 11.1
34 3mc syndrome 2 11.1
35 ifap syndrome with or without bresheck syndrome 11.1
36 robinow syndrome, autosomal recessive 2 11.1
37 genitourinary and/or brain malformation syndrome 11.1
38 froster-huch syndrome 11.1
39 methimazole antenatal exposure 11.1
40 colonic atresia 10.3
41 neural tube defects 10.3
42 exstrophy of bladder 10.3
43 peritonitis 10.2
44 intestinal obstruction 10.2
45 macroglossia 10.2
46 gastric dilatation 10.2
47 prune belly syndrome 10.2
48 mercury poisoning 10.2
49 chlamydia 10.2
50 cryptorchidism, unilateral or bilateral 10.2

Graphical network of the top 20 diseases related to Abdominal Wall Defect:

Diseases related to Abdominal Wall Defect

Symptoms & Phenotypes for Abdominal Wall Defect

Drugs & Therapeutics for Abdominal Wall Defect

Drugs for Abdominal Wall Defect (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 103)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
Morphine Approved, Investigational Phase 4 57-27-2 5288826
Glycerol Approved, Investigational Phase 4 56-81-5 753
5 Coconut Approved Phase 4
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
Sorbitol Approved Phase 4 50-70-4 5780
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
9 Tocotrienol Investigational Phase 4 6829-55-6
10 Anesthetics, Local Phase 4
11 Ketorolac Tromethamine Phase 4
12 Protective Agents Phase 4
13 Gastrointestinal Agents Phase 4
14 Fat Emulsions, Intravenous Phase 4
15 Liver Extracts Phase 4
16 Pharmaceutical Solutions Phase 4
17 Soybean oil, phospholipid emulsion Phase 4
18 Parenteral Nutrition Solutions Phase 4
19 Soy Bean Phase 4
20 Laxatives Phase 4
21 Olive Phase 4
22 Cathartics Phase 4
23 Tocotrienols Phase 4
24 Tocopherols Phase 4
leucovorin Approved Phase 3 58-05-9 6006 143
Neostigmine Approved, Vet_approved Phase 3 59-99-4 4456
Metoclopramide Approved, Investigational Phase 3 364-62-5 4168
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
30 Trace Elements Phase 3
31 Vitamins Phase 3
32 Vitamin B Complex Phase 3
33 Hematinics Phase 3
34 Folate Phase 3
35 Nutrients Phase 3
36 Vitamin B9 Phase 3
37 Micronutrients Phase 3
38 Omega 3 Fatty Acid Phase 2, Phase 3
Bilirubin Phase 2, Phase 3 69853-43-6, 635-65-4 21252250 5280352
40 Anesthetics Phase 3
41 Neuromuscular Blocking Agents Phase 3
42 Neurotransmitter Agents Phase 3
43 Dopamine Agents Phase 3
44 Dopamine Antagonists Phase 3
45 Antiemetics Phase 3
Acetaminophen Approved Phase 2 103-90-2 1983
Ibuprofen Approved Phase 2 15687-27-1 3672
Oxycodone Approved, Illicit, Investigational Phase 2 76-42-6 5284603
Erythromycin Approved, Investigational, Vet_approved Phase 2 114-07-8 12560 441411
Glucagon Approved Phase 1, Phase 2 16941-32-5

Interventional clinical trials:

(show top 50) (show all 124)
# Name Status NCT ID Phase Drugs
1 Evaluation of the Safety and Efficacy of EXPAREL® When Infiltrated Into the Transversus Abdominis Plane (TAP) for Prolonged Postoperative Analgesia in Subjects Undergoing Unilateral Abdominal Hernia Repair Completed NCT01801124 Phase 4 EXPAREL
2 Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair Completed NCT02128646 Phase 4 EXPAREL;Ketorolac
3 Results of Open Mesh Versus Suture Repair in Treatment of Abdominal Wall (Multicentric, Prospective, Randomised, Internet-based, Clinical Trial) Completed NCT01018524 Phase 4
4 Assistance Robotics for the Surgical Treatment of the Abdominal Wall Hernia Completed NCT00908193 Phase 4
5 A Randomized, Prospective, Double-blind, Multi-Center Study To Examine And Compare The Outcomes Associated With The Use Of Flex HD®, A Human Acellular Dermal Matrix, And Strattice™, A Porcine Acellular Dermal Matrix Allograft, When Used As A Reinforcing Material In The Repair Of Large Abdominal Wall Hernias By A Component Separation Technique Completed NCT01987700 Phase 4
6 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
7 The Use of Gastrografin to Help Alleviate Bowel Obstruction Related to Poor Bowel Motility in Gastroschisis Patients. Recruiting NCT03334578 Phase 4 Gastrografin
8 Evaluation of Routine Administration of Glycerin Suppositories to Improve Bowel Function in Patients With Uncomplicated Gastroschisis Recruiting NCT03355326 Phase 4 Glycerin Suppository
9 A Multicenter, Prospective, Single-Blind, Randomized, Controlled Study of the Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair Terminated NCT01083472 Phase 4
10 Low Dose Parenteral Fat for the Prevention of Parenteral Nutrition Associated Cholestasis in Neonates With Congenital/Acquired Gastrointestinal Disorders Terminated NCT01373918 Phase 4 Intralipid;Intralipid
11 Incidence and Severity of Parenteral Nutrition Associated Cholestasis in Neonates Subjected to Major Surgery, Using Two Mixed Intravenous Lipid Emulsions Terminated NCT02633384 Phase 4
12 Randomized Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Unknown status NCT00127946 Phase 3
13 Randomized Clinical Trial to Evaluate the Efficacy of High Dose of Folic Acid to Prevent the Occurrence of Congenital Malformations Unknown status NCT01244347 Phase 3 folic acid;folic acid
14 The Use of Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature and Very-low Birth Weight Infants Completed NCT01868737 Phase 3
15 The North American Study for the Treatment of Refractory Ascites (NASTRA) Clinical Trial Completed NCT00006166 Phase 3
16 Fish Oil Lipid Emulsion for the Treatment of Parenteral-Nutrition-Associated Liver Disease in Infants Completed NCT02370251 Phase 2, Phase 3 Omegaven
17 Gastroschisis Outcomes of Delivery (GOOD) Study Recruiting NCT02774746 Phase 3
18 Evaluation of Sugammadex Vs. Neostigmine in the PACU for Abdominal Surgeries Not yet recruiting NCT04096144 Phase 3 Neuromuscular Blocking Agents
19 The Use of Metoclopramide vs. Placebo in Infants With Gastroschisis. A Pilot Double Blind Randomized Controlled Trial Terminated NCT02098915 Phase 3 intravenous metoclopramide
20 Abdominal Wall Closure After TRAM / DIEP Flap - Comparison of TIGR Mesh vs Polypropylene Mesh. Unknown status NCT01136603 Phase 2
21 The Buckypaper as a New Device in the Treatment of Some Solid Cancer and Hematopoietic System Tumors and as a New Fixing Device for Prosthetic Surgery. In Vivo Study on Effects of BP Implantation, Preliminary to Human Surgical Applications Unknown status NCT02328352 Phase 1, Phase 2
22 A Multi-Centre, Prospective Randomized Trial to Evaluate Routine Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis Completed NCT00539292 Phase 2
23 Compassionate Use of an Intravenous Fish Oil Lipid Emulsion (Omegaven®) for the Treatment of Intestinal Failure Associated Liver Disease in Children Completed NCT02328768 Phase 2 Omegaven
24 The Effect of Multimodal Pain Therapy After Hernia Repair Not yet recruiting NCT03792295 Phase 2 acetominophen, ibuprofen, oxycodone;Oxycodone
25 Phase 2 Study of Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis for Very Low Birth Weight Infants -Multi-Center Randomized Control Trial Terminated NCT00540033 Phase 2
26 Phase 1-2 Trial of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Terminated NCT01573286 Phase 1, Phase 2 Glucagon-Like Peptide 2;Glucagon like peptide-2
27 An Open-label, Single-arm, Phase 1 Study Examining the Safety and Efficacy of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias (HiP_1 Trial) Following Abdominal Surgery Withdrawn NCT02584153 Phase 1 Fibrin Sealant;Silver Microparticles
28 The Use of Elemental Formula in Neonates Post Small Bowel Resection: Improved Success to Wean From Total Parenteral Nutrition? Unknown status NCT01891279
29 Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy Unknown status NCT01855347
30 Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy Unknown status NCT02534090
31 Full-thickness Skin vs. Synthetic Mesh in the Repair of Large Incisional Hernia - a Prospective Randomized Controlled Study Unknown status NCT01413412
32 Repair of Complex Recurrent Incisional Hernias With The Bony Anchoring Reinforcement System (BARS) Unknown status NCT01644695
33 The Effect of Music Therapy On Infants Born With Gastroschisis Unknown status NCT01469208
34 Mesh Used Repairs in Emergency Abdominal Wall Hernias Unknown status NCT01578538
35 Study for the Evaluation of the Efficiency of a Device for the Diagnosis of an Internal Rectal Prolapse, a Pelvic Floor Ptosis and for the Determination of an Internal Hernia Into the Douglas Pouch Unknown status NCT00836680
36 A Prospective Randomized Study to Evaluate Two Different Surgical Methods for Treatment for Abdominal Wall Diastasis Unknown status NCT01586741
37 Abdominal CT Angiography of Mesenteric Vessels for Diagnosing Internal Herniation After Roux-en-Y Gastric Bypass Surgery Unknown status NCT03114761
38 PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial Unknown status NCT02594241 Methyl-Prednisolone;Physiological saline
39 Case-control Study of Mesh-infection After a Size Tailored Hernia Repair With C-Qur V-Patch Unknown status NCT01761708
40 Anterior Transversalis Fascia Approach Versus Preperitoneal Space Approach for Inguinal Hernia Repair in Residents in Northern China: a Prospective, Multi-center, Randomized, Controlled Trial Unknown status NCT02984917
41 Post-Operative Pain After Laparoscopic Ventral Hernia Repair, Impact of Mesh Impregnation With Bupivacaine Solution vs. Normal Saline Solution Unknown status NCT03035617 Bupivacaine
42 Probiotics Supplementation and Length of Hospital Stay in Neonates With Gastrointestinal Surgery Unknown status NCT03266315
43 Health Related Quality of Life of Patients With Abdominal Wall Defects Completed NCT03960320
44 A Multicenter, Prospective, Observational Evaluation of Repair of Infected or Contaminated Hernias (RICH) Using LTM Completed NCT00617357
45 Repair of Large Abdominal Hernia Defects By A Novel Biologic Mesh: A Prospective Multi-Center Observational Study Completed NCT00892333
46 Quality of Life Evaluations in Patients With Abdominal Wall Hernias Completed NCT01115400
47 Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? Completed NCT02787772
48 Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair Completed NCT02575846
49 Collagen Alterations in Patients With Abdominal Wall Hernias Completed NCT02734563
50 Intra-Abdominal Hypertension in Neonatal Intensive Care Patients Completed NCT00747552

Search NIH Clinical Center for Abdominal Wall Defect

Genetic Tests for Abdominal Wall Defect

Anatomical Context for Abdominal Wall Defect

MalaCards organs/tissues related to Abdominal Wall Defect:

Liver, Small Intestine, Heart, Lung, Colon, Skin, Testes

Publications for Abdominal Wall Defect

Articles related to Abdominal Wall Defect:

(show top 50) (show all 3111)
# Title Authors PMID Year
Birth prevalence of congenital anomalies in the City of Buenos Aires, Argentina, according to socioeconomic level. 61
31900751 2020
Prenatal detection of congenital anomalies and related factors in Argentina. 61
31900752 2020
Ultrasound markers for prediction of complex gastroschisis and adverse outcome: longitudinal prospective nationwide cohort study. 61
31613023 2020
Pediatric Surgery Simulation-Based Training for the General Surgery Resident. 61
32561030 2020
Gastroschisis: further investigation warranted. 61
32533927 2020
Inflammatory Bowel Disease and Risk of Birth Defects in Offspring. 61
31907519 2020
Clues and pitfalls in prenatal diagnosis of classic cloacal exstrophy using ultrasonography and magnetic resonance imaging: A case with sequential observation from 17 to 30 weeks' gestation and literature review. 61
32537902 2020
Reconstruction of Complex Abdominal Wall Defect With Autogenous Pedicled Demucosalized Seromuscular Flap. 61
32433332 2020
The Importance of Abdominal Wall Closure After Definitive Surgery for Enterocutaneous Fistula. 61
32556420 2020
Determining maternal risk factors for gastroschisis using colorado's birth registry database. 61
32173119 2020
Risk factors for gastroschisis: A case-control study in a Brazilian population. 61
32115707 2020
Maternal occupational exposure to solvents and gastroschisis in offspring: are gene-environment interactions playing a role? 61
32513830 2020
Abdominal Wall Defects. 61
32482700 2020
Variation in hospital costs for gastroschisis closure techniques. 61
32199604 2020
Gastroschisis Is Associated With Placental Delayed Villous Maturation. 61
31542993 2020
Presence of congenital anomalies in three dog litters. 61
32003081 2020
Decentralized surgery of abdominal wall defects in Germany. 61
32219563 2020
Sex differences in surgically correctable congenital anomalies: A systematic review. 61
32061363 2020
A new technique for the 3D reconstruction of the incisional hernia: A pilot study. 61
32531694 2020
Retrospective analysis of defect reconstruction after abdominal wall tumor resection in 30 patients. 61
32451791 2020
Reconstruction of abdominal wall with scaffolds of electrospun poly (l-lactide-co caprolactone) and porcine fibrinogen: An experimental study in the canine. 61
32204076 2020
Platelet-rich fibrin prevents postoperative intestinal adhesion. 61
31943765 2020
Application of the novel enhanced transabdominal preperitoneal (ETAP) technique for laparoscopic suprapubic incisional hernia repair. 61
31538257 2020
Major abdominal wall defects in the low- and middle-income setting: current status and priorities. 61
32200405 2020
Prevalence and predictors of mortality in gastroschisis: a population-based study of 4803 cases in the USA. 61
30477359 2020
Antenatal corticosteroids and outcomes in gastroschisis: A multicenter retrospective cohort study. 61
32400889 2020
Whole exome sequencing identifies multiple novel candidate genes in familial gastroschisis. 61
32163230 2020
Maternal risk factors for gastroschisis: A population-based case-control study. 61
32406607 2020
Impact of Clinical Factors on the Intestinal Microbiome in Infants With Gastroschisis. 61
32441784 2020
Reducing Gastroschisis Mortality: A Quality Improvement Initiative at a Ugandan Pediatric Surgery Unit. 61
31965276 2020
Intraoperative Findings Associated to Inpatient Mortality From Patients With Gastroschisis in Western Mexico. 61
32417497 2020
Extra-abdominal Cryptorchidism Associated With Gastroschisis and Impacted Urethral Calculus: Two Uncommon Urologic Conditions in One Patient. 61
32320791 2020
Use of autologous dermal flap as mesh coverage in the treatment of large abdominal-wall defect in patients following massive weight loss: presentation of a novel surgical technique. 61
32062712 2020
Prenatal Diagnosis of a Ventral Abdominal Wall Defect. 61
32238493 2020
Multidisciplinary treatment of abdominal wall endometriosis: A case report and literature review. 61
32361342 2020
Accuracy of sonographic estimation of weight in fetuses with abdominal wall defects. 61
32291746 2020
Utility of Formulas Using Fetal Thigh Soft Tissue Thickness in Estimating Weight in Gastroschisis. 61
32320090 2020
Gastroschisis in the neonatal period: A prospective case-series in a Brazilian referral center. 61
32467036 2020
The association between gestational age at delivery, closure type and perinatal outcomes in neonates with isolated gastroschisis. 61
30173575 2020
Epidemiology and outcomes of gastroschisis in Tasmania. 61
32196139 2020
Growth from Birth to 30 months for Infants Born with Congenital Gastrointestinal Anomalies and Disorders. 61
32168528 2020
Congenital multiple colonic atresias with intestinal malrotation: a case report. 61
32232592 2020
Factors Related to the Development of Small-Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Retrospective Cohort Study. 61
32167608 2020
Canadian Cannabis Consumption and Patterns of Congenital Anomalies: An Ecological Geospatial Analysis. 61
32187114 2020
Defining the critical pediatric surgical workforce density for improving surgical outcomes: a global study. 61
31839371 2020
Cranial tibial fascia autograft for wound closure following hemipelvectomy in a cat. 61
32165749 2020
Resection and Reconstruction of Giant Abdominoscrotal Arteriovenous Malformation. 61
32537371 2020
Application of double circular suturing technique (DCST) in the repair of large abdominal wall defects after resection of abdominal wall tumor. 61
32355811 2020
Donor mesenchymal stem cell kinetics after transamniotic stem cell therapy (TRASCET) in a rodent model of gastroschisis. 61
31813581 2020
Gastroschisis prevalence substantially decreased from 2009 through 2018 after a 3-fold increase from 1997 to 2008. 61
32276850 2020

Variations for Abdominal Wall Defect

ClinVar genetic disease variations for Abdominal Wall Defect:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 46;X;t(X;10)(p11.2;q24.3)Translocation Uncertain significance 267803

Expression for Abdominal Wall Defect

Search GEO for disease gene expression data for Abdominal Wall Defect.

Pathways for Abdominal Wall Defect

GO Terms for Abdominal Wall Defect

Sources for Abdominal Wall Defect

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....